Conflicts of interest Dr Wambier has served as an adviser for Chemistry Rx, Daniel Alain, and Young Pharmaceuticals and as an investigator for Incyte, Eli Lilly, Pfizer, SunPharma, and UCB
Refer to Table 10 and Figure 1
Your clinician can give nutrition and exercise recommendations and determine whether a weight loss medication like a GLP-1 may be a good option for you
Despite higher doses, IGF-1 increases often more modest (40-70 ng/mL) reflecting reduced secretory capacity
On Healthcare Matters, were talking about the turmoil surrounding ACIP, which is the CDCs Advisory Committee on Immunization Practices
Blood Sugar Control Ben Greenfield keeps a close eye on his glucose response, especially during higher-carb meals